Pharm2Farm part of Nanosynth group is an AIM listed plc. Nanosynth currently has two operating subsidiaries, Pharm2Farm Ltd and Virosynth Ltd. The Group focuses on nanotechnology and advanced materials.
Pharm2Farm has worldwide licenses for two patents relating to nanoparticle production and has filed two additional patents. Pharm2Farm produce and sell these products through a licence to this technology from Nottingham Trent University, UK.
Pharm2Farm has developed and patented a process to produce nanoparticles for several applications. This uses bespoke nanotechnology coating processes to dramatically increase the performance of nanoparticles across applications in comparison to standard methodologies.